Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 206,166,890 papers from all fields of science
Search
Sign In
Create Free Account
Camptothecin Analogue TLC388
A synthetic analogue of camptothecin with potential antineoplastic and radio-sensitizing activities. Camptothecin analogue TLC388 selectively…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Narrower (1)
TLC 388
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2011
2011
A phase I study of the novel DNA topoisomerase-1 inhibitor, TLC388, administered intravenously to patients with advanced solid tumors.
S. Ghamande
,
C. Lin
,
+9 authors
S. Goel
Journal of clinical oncology : official journal…
2011
Corpus ID: 8389494
e13618 Background: The phase I first-in-human study of TLC388 (Lipotecan) examined the MTD, safety, anti-tumor activity and…
Expand
2011
2011
Abstract A89: A phase I study of the novel DNA topoisomerase-1 inhibitor, TLC388 (Lipotecan®), administered intravenously to patients with advanced solid tumors.
S. Ghamande
,
Chia‐Chi Lin
,
+10 authors
S. Goel
2011
Corpus ID: 84034224
Introduction: TLC388 (Lipotecan) is a potent Topoisomerase-1 inhibitor and it can disrupt both Sonic Hedgehog and HIF1-α pathways…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
,
Terms of Service
, and
Dataset License
ACCEPT & CONTINUE